نتائج البحث

Effectiveness of Predicted Low-Glucose Suspend Pump Technology in the Prevention of Hypoglycemia in People with Type 1 Diabetes Mellitus: Real-World Data Using DIA:CONN G8.

• Authors : Jee Hee Yoo^1,2; Ji Yoon Kim³; Jae Hyeon Kim³

• Source: Diabetes & Metabolism Journal. Jan2025, Vol. 49 Issue 1, p144-149. 7p.

تفاصيل العنوان

Diabetic Ketoacidosis as an Effect of Sodium-Glucose Cotransporter 2 Inhibitor: Real World Insights.

• Authors : Baek HS; Division of Endocrinology and Metabolism, Department of Internal Medicine, Uijeongbu St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Uijeongbu, Korea.; Jeong C

Subjects: Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/Diabetic Ketoacidosis*/chemically induced ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Nov; Vol. 48 (6), pp. 1169-1175. Date of Electronic Publication: 2024 Jun 10.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

Benefit and Safety of Sodium-Glucose Co-Transporter 2 Inhibitors in Older Patients with Type 2 Diabetes Mellitus.

• Authors : Ja Young Jeon¹; Dae Jung Kim¹

• Source: Diabetes & Metabolism Journal. Sep2024, Vol. 48 Issue 5, p837-846. 10p.

تفاصيل العنوان

Association of Measures of Glucose Metabolism with Colorectal Cancer Risk in Older Chinese: A 13-Year Follow-up of the Guangzhou Biobank Cohort Study-Cardiovascular Disease Substudy and Meta-Analysis.

• Authors : Shu Yi Wang¹; Wei Sen Zhang²; Chao Qiang Jiang²

• Source: Diabetes & Metabolism Journal. Jan2024, Vol. 48 Issue 1, p134-145. 12p.

تفاصيل العنوان

Abrupt Decline in Estimated Glomerular Filtration Rate after Initiating Sodium-Glucose Cotransporter 2 Inhibitors Predicts Clinical Outcomes: A Systematic Review and Meta-Analysis.

• Authors : Chuang MH; Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.; Tang YS

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/adverse effects ; Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/etiology

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 242-252. Date of Electronic Publication: 2024 Jan 26.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95).

• Authors : Bae JH; Department of Internal Medicine, Korea University Anam Hospital, Korea University College of Medicine, Seoul, Korea.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Jan; Vol. 48 (1), pp. 157-158. Date of Electronic Publication: 2024 Jan 29.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition (Diabetes Metab J 2023;47:784-95).

• Authors : Lee HG; Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.; Jung IH

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Jan; Vol. 48 (1), pp. 159-160. Date of Electronic Publication: 2024 Jan 29.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

Comparative Effect of Glucose-Lowering Drugs for Type 2 Diabetes Mellitus on Stroke Prevention: A Systematic Review and Network Meta-Analysis.

• Authors : Kim JS; International Healthcare Center, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, Korea.; Lee G

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/chemically induced

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2024 Mar; Vol. 48 (2), pp. 312-320. Date of Electronic Publication: 2024 Jan 26.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

Altered Metabolic Phenotypes and Hypothalamic Neuronal Activity Triggered by Sodium-Glucose Cotransporter 2 Inhibition.

• Authors : Lee HG; Division of Life Sciences, College of Life Sciences and Bioengineering, Incheon National University, Incheon, Korea.; Jung IH

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology; Humans ; Mice

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2023 Nov; Vol. 47 (6), pp. 784-795. Date of Electronic Publication: 2023 Aug 23.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان

Risk of Diabetic Retinopathy between Sodium-Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists (Diabetes Metab J 2023;47:394-404).

• Authors : Lin TY; Department of Education, Chang Gung Memorial Hospital, Linkou Medical Center, Taoyuan, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Diabetic Retinopathy*/Diabetic Retinopathy*/Diabetic Retinopathy*/drug therapy

• Source: Diabetes & metabolism journal [Diabetes Metab J] 2023 Jul; Vol. 47 (4), pp. 573-574. Date of Electronic Publication: 2023 Jul 27.Publisher: Korean Diabetes Association Country of Publication: Korea (South) NLM ID: 101556588 Publication Model:

تفاصيل العنوان